Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-040967

Options or other derivatives

  • See Remarks acquired 12,784 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Cadavid Diego See Remarks 2019-07-18 Grant or award · Stock Option (right to buy) +12,784 12,784 D
Loading xslF345X03/a4.xml…